153 related articles for article (PubMed ID: 29405341)
1. Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component.
Campbell K; Kumarapeli AR; Gokden N; Cox RM; Hutchins L; Gardner JM
J Cutan Pathol; 2018 May; 45(5):360-364. PubMed ID: 29405341
[TBL] [Abstract][Full Text] [Related]
2. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
[TBL] [Abstract][Full Text] [Related]
3. Primary Dedifferentiated Amelanotic Anorectal Melanoma: Report of a Rare Case.
Bell PD; Israel AK; Dunn AL; Liao X
Int J Surg Pathol; 2019 Dec; 27(8):923-928. PubMed ID: 31232138
[TBL] [Abstract][Full Text] [Related]
4. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
Tran TAN; Linos K; de Abreu FB; Carlson JA
Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous malignant melanoma with rhabdomyosarcomatous differentiation originating from a melanocytic nevus in a patient with myelodysplastic syndrome.
Yim SH; Kim D; Hong D; Jung KE; Lee Y; Seo YJ; Park S
J Cutan Pathol; 2022 Oct; 49(10):875-880. PubMed ID: 35707850
[TBL] [Abstract][Full Text] [Related]
6. Undifferentiated Sarcoma as Intermediate Step in Rhabdomyosarcomatous Transformation of a Metastatic Malignant Melanoma Resistant to Anti-BRAF Therapy: A Phenomenon Associated With Significant Diagnostic and Therapeutic Pitfalls.
Tran TAN
Int J Surg Pathol; 2019 Sep; 27(6):669-677. PubMed ID: 30942107
[TBL] [Abstract][Full Text] [Related]
7. Loss of Conventional Melanocytic Markers in Malignant Melanoma and Lymph Node Metastasis; an Uncommon but Dangerous Pitfall.
Chang O; Argenyi Z
Am J Dermatopathol; 2017 Oct; 39(10):760-763. PubMed ID: 27759690
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic Melanoma With Desmin Expression.
Trevisan F; Tregnago AC; Lopes Pinto CA; Urvanegia ACM; Morbeck DL; Bertolli E; Riva Neto FR; Duprat Neto JP; de Macedo MP
Am J Dermatopathol; 2017 Jul; 39(7):528-533. PubMed ID: 27655122
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated Melanoma With Expression of Cytokeratin and GATA3 in a Patient With History of Breast Carcinoma.
Alkhasawneh A; Nassri A; John I
Am J Dermatopathol; 2019 Jul; 41(7):502-504. PubMed ID: 30562218
[TBL] [Abstract][Full Text] [Related]
10. Living on the Edge: Diagnosing Sarcomatoid Melanoma Using Histopathologic Cues at the Edge of a Dedifferentiated Tumor: A Report of 2 Cases and Review of the Literature.
Erstine EM; Tetzlaff MT; Ko JS; Prieto VG; Cheah AL; Billings SD
Am J Dermatopathol; 2017 Aug; 39(8):593-598. PubMed ID: 27655123
[TBL] [Abstract][Full Text] [Related]
11. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
Vrotsos E; Alexis J
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
[TBL] [Abstract][Full Text] [Related]
12. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
13. Metastatic Melanoma Negative for 5 Melanocytic Markers, Complete Regressed Primary Cutaneous Melanoma, and Melanoma-Associated Leukoderma in the Same Patient.
Ramos-Rodríguez C; García-Arpa M; Relea-Calatayud MF; González-López L; Romero-Aguilera G
Am J Dermatopathol; 2020 Dec; 42(12):956-960. PubMed ID: 32809978
[TBL] [Abstract][Full Text] [Related]
14. Primary de-differentiated, trans-differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum.
Ferreira I; Arends MJ; van der Weyden L; Adams DJ; Brenn T
Histopathology; 2022 Jan; 80(1):135-149. PubMed ID: 34958502
[TBL] [Abstract][Full Text] [Related]
15. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
Kooper-Johnson S; Mahalingam M; Loo DS
Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
[TBL] [Abstract][Full Text] [Related]
16. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Melanoma With Features of Desmoplastic Melanoma in a Patient With Primary Cutaneous Superficial Spreading Melanoma With Epithelioid Features.
Modi MB; Moshiri AS; Klein WM; Karakousis G; Shafique K; Xu X
Am J Dermatopathol; 2021 May; 43(5):377-380. PubMed ID: 33464752
[TBL] [Abstract][Full Text] [Related]
18. Desmoplastic melanoma with sarcomatoid dedifferentiation.
Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
[TBL] [Abstract][Full Text] [Related]
19. [Gallbladder metastasis of melanoma: Immunohistochemical and molecular data of a case and review of the literature].
Tauziède-Espariat A; Raffoul J; Sun SR; Monnin C; de la Fouchardière A; Lassabe C
Ann Pathol; 2017 Dec; 37(6):484-487. PubMed ID: 29153887
[TBL] [Abstract][Full Text] [Related]
20. A case of collision tumor or transdifferentiation between malignant melanoma and leiomyosarcoma.
Ul-Mulk J; Rasmussen H; Breiting L; Siim E
Indian J Pathol Microbiol; 2012; 55(4):538-9. PubMed ID: 23455799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
